Abstract Submission on the Web

Abstract Receipt Deadline: 11:59 PM, the night of June 7, 2007 (US East Coast time).

Rules and instructions for completing and submitting abstracts are posted at the submission site.
For reference in preparing your submission, a list of abstract topics and keywords may be reviewed below.

Abstract Topics 2007

From the following list, authors will be asked to select one topic number, and within that topic number, the one letter of the description that most closely describes the work submitted.

1.  CANCER CYTOGENETICS
	a.	Chromosomal and genomic changes in cancer
	b.	Molecular cytogenetic characterization (including FISH and microarray)
	c.	Mechanisms of rearrangements or disease progression
	d.	Risk assessment, prognosis, and treatment
	e.	Imprinting
	f.	Epidemiology
	g.	Molecular basis
	h.	Other
TOP OF PAGE

2.  CANCER GENETICS
	a.	New syndromes, associations (clinical)
	b.	New components of an existing syndrome (clinical)
	c.	Clinical assessment, prognosis, and treatment of inherited cancer syndromes
	d.	Mouse models of inherited cancer and predisposition
	e.	Epidemiology
	f.	Molecular understanding of cancer genesis, progression and treatment
	g.	Other
TOP OF PAGE

3.  CARDIOVASCULAR GENETICS
	a.	Description of new syndromes
	b.	Diagnostics
	c.	Development
	d.	Candidate genes/regions
	e.	Whole genome association studies
	f.	Gene-environment interactions
	g.	Other
TOP OF PAGE

4.  CLINICAL GENETICS, MALFORMATIONS AND DYSMORPHOLOGY
	a.	Natural history of genetic syndromes/diseases
	b.	Characterization of syndromes
	c.	Description of new syndromes
	d.	Molecular basis of syndromes/malformations
	e.	Mental retardation
	f.	Brain/central nervous system disorders
	g.	Vision/hearing disorders
	h.	Bone/joint/muscular disorders
	i.	Cardiovascular/connective tissue disorders
	j.	Endocrine disorders
	k.	Gastrointestinal/digestive disorders
	l.	Genitourinary disorders
	m.	Pulmonary disorders
	n.	Genotype-phenotype correlations
	o.	Malformation
	p.	Dysmorphology
	q.	Other
TOP OF PAGE

5.  CYTOGENETICS
	a.	Cytogenetics
	b.	Chromosome structure
	c.	Chromosomes and disease
	d.	Chromosome rearrangements
	e.	Mechanisms of chromosome rearrangements
	f.	Aneuploidy
	g.	Chromosome stability and maintenance
	h.	X inactivation
	i.	Molecular cytogenetic technologies (includes FISH, microarrays, etc.)
	j.	Imprinting
	k.	Meiosis, normal or abnormal
	l.	Other
TOP OF PAGE

6.  DEVELOPMENT
	a.	Neurodevelopment
	b.	Cardiovascular development
	c.	Model organism
	d.	Organogenesis
	e.	Neural crest migration
	f.	Other
TOP OF PAGE

7.  EPIGENETICS
	a.	Methylation
	b.	Histone modification
	c.	Short RNAs
	d.	Other
TOP OF PAGE

8.  ETHICAL, LEGAL AND SOCIAL ISSUES IN GENETICS
	a.	Ethical dilemmas
	b.	Family issues
	c.	Public health initiatives
	d.	Legal and social implications of genomics
	e.	Public policy issues
	f.	Genetic screening
	g.	Other
TOP OF PAGE

9.  EVOLUTIONARY AND POPULATION GENETICS
	a.	Mutation and polymorphism
	b.	Population history and relationships
	c.	Population isolates and founder mutations
	d.	Natural selection and adaptation
	e.	Molecular evolution
	f.	Other
TOP OF PAGE

10.  GENE STRUCTURE AND FUNCTION
	a.	Gene sequence
	b.	Genome structure
	c.	Gene regulation
	d.	Gene families
	e.	Functional motifs
	f.	Other
TOP OF PAGE

11.  GENETIC COUNSELING AND CLINICAL TESTING
	a.	Genetic Counseling
	b.	Risk Assessment
	c.	Genetic education
	d.	Psychological assessment
	e.	Carrier testing
	f.	Predisposition testing
	g.	Other
TOP OF PAGE

12.  GENETICS EDUCATION
	a.	K-16/Public
	b.	Graduate and medical
	c.	Continuing/professional
	d.	Other
TOP OF PAGE

13.  GENOMICS
	a.	Physical mapping
	b.	Comparative mapping
	c.	Sequence analysis
	d.	Technology development
	e.	Genome-wide profiling
	f.	Proteomics
	g.	Bioinformatics
	h.	Other
TOP OF PAGE

14.  METABOLIC DISORDERS
	a.	Description of new disorders
	b.	Natural history of known disorders
	c.	Biochemical basis of a disease
	d.	Molecular basis of an inborn error
	e.	Newborn screening
	f.	Diagnostic studies
	g.	Other
TOP OF PAGE

15.  MAPPING, LINKAGE AND LINKAGE DISEQUILIBRIUM
	a.	Methods specific to these areas
	b.	Applications and results of analyses
	c.	Other
TOP OF PAGE

16.  MOLECULAR BASIS OF DISORDERS WITH COMPLEX INHERITANCE
	a.	Hypothesis testing in candidate genes/regions
	b.	Replication of susceptibility genes/allele
	c.	Complex diseases
	d.	Joint application of statistical and molecular methods
	e.	Integration of genetics and genomics
	f.	Pharmacogenetics
	g.	Other
TOP OF PAGE

17.  MOLECULAR BASIS OF MENDELIAN DISORDERS
	a.	Multiple congenital anomaly syndromes
	b.	Skeletal disorders
	c.	Neurogenetic disorders
	d.	Cardiovascular disorders
	e.	Gastrointestinal disorders
	f.	Hematopoietic/immunologic defects
	g.	Respiratory defects
	h.	Renal/genitourinary defects
	i.	Endocrinological defects
	j.	Animal Models
	k.	Geneotype-phenotype correlations
	l.	Biochemical characterization
	m.	Functional characterization
	n.	Other
TOP OF PAGE

18.  PHARMACOGENETICS
	a.	Pharmacodynamics
	b.	Pharmacokinetics
	c.	Somatic pharmacogenetics
	d.	Small molecule screening and in vitro
	e.	Social, policy, regulatory, and economic implications
	f.	Other
TOP OF PAGE

19.  PRENATAL AND PERINATAL GENETICS
	a.	Prenatal diagnosis
	b.	Fetal therapy
	c.	Genetic screening
	d.	Fetal imaging
	e.	Maternal serum screening
	f.	Other
TOP OF PAGE

20.  PSYCHIATRIC GENETICS AND NEUROGENETICS
	a.	Description of disorders
	b.	Diagnostic
	c.	Development
	d.	Candidate genes/regions
	e.	Whole genome association studies
	f.	Gene-environment interactions
	g.	Other
TOP OF PAGE

21.  PUBLIC POLICY
	a.	Survey
	b.	Analysis
	c.	Other
TOP OF PAGE

22.  REPRODUCTIVE GENETICS
	a.	Infertility
	b.	Assisted reproductive technologies
	c.	Preimplantation diagnosis
	d.	Ethical, legal, social issues
	e.	Other
TOP OF PAGE

23.  STATISTICAL GENETICS AND GENETIC EPIDEMIOLOGY
	a.	Inheritance modeling
	b.	Mathematical methods in genetics
	c.	Penetrance estimation, methods to study genotype/phenotype relationships
	d.	Gene-gene and gene-environment interaction modeling
	e.	Distribution and predictors of genetic and complex diseases in families and populations
	f.	Design and conduct of genetic studies
	g.	Other
TOP OF PAGE

24.  THERAPY FOR GENETIC DISORDERS
	a.	Drug treatments
	b.	Bone marrow or whole organ transplantation
	c.	Gene therapy
	d.	Symptomatic therapy
	e.	Dietary therapy
	f.	Other
TOP OF PAGE

---

Keywords

Authors may choose up to five of the following keywords to assist others in locating their abstracts. The corresponding keyword number(s) should be entered as indicated in the abstract submission program:

1. amino acidemias
2. assisted reproduction
3. auditory system
4. biochemical pathology
5. biogenesis
6. bioinformatics
7. bone marrow transplantation
8. bone/joint abnormalities
9. brain/nervous system
10. cancer cytogenetics
11. cancer syndromes
12. candidate gene
13. cardiovascular system
14. cellular metabolism
15. characterization of disorders
16. characterization of syndromes
17. chromosomal abnormalities
18. chromosomal deletions
19. chromosomal structure/function
20. clinical applications of molecular cytogenetics
21. clinical cytogenetics
22. clinical history
23. comparative mapping
24. computational tools
25. congenital anomaly
26. contigs
27. counseling
28. CVD
29. databases
30. deformation
31. delineation of diseases
32. development
33. diabetes
34. diagnostics
35. differentiation
36. disruption
37. dysmorphology
38. education
39. epidemiology
40. endocrine system
41. enzyme replacement therapy
42. ethical, legal and social issues
43. etiology
44. evolution
45. evolutionary genetics
46. expansion
47. family linkage analysis
48. fetal pathology
49. fetal therapy
50. FISH
51. functional motifs
52. gastrointestinal system
53. gene environment interaction
54. gene families
55. gene localization
56. gene therapy
57. gene transfer methodologies
58. genes in development
59. genetic diversity
60. genetic epidemiology
61. genetic testing
62. genitourinary system
63. genome scan
64. genome sequencing
65. genome-wide association
66. genomic methodologies
67. genomic structure
68. genotype-phenotype correlations
69. haplotype
70. hematopoietic system
71. identification of disease genes
72. immune system
73. imprinting
74. infertility
75. inheritance modeling
76. inheritance patterns
77. limb
78. linkage disequilibrium
79. linkage mapping
80. linkage methodology
81. lymphatic system
82. lysosomal diseases
83. malformation
84. mapping complex traits
85. maps
86. maternal genetic disease
87. maternal serum screening
88. mathematical modeling
89. mental retardation
90. metabolic disorder
91. methodology
92. methylation
93. mitochondria
94. model organisms
95. molecular pathophysiology
96. morphogenesis
97. muscular abnormalities
98. mutation detection
99. natural history
100. natural selection
101. newborn screening
102. oncogenesis
103. organic acidurias
104. pathogenesis
105. peroxisomal diseases
106. pharmacodynamics
107. pharmacogenetics
108. pharmacokinetics
109. pharmacologic therapy
110. phenotype
111. physical mapping
112. policy issues
113. polymorphism
114. population genetics
115. population structure
116. predictive testing
117. preimplantation diagnosis
118. prenatal diagnosis
119. proteomics
120. psychosocial counseling issues
121. psychosocial issues
122. public health
123. public, patient and professional education
124. regulation of transcription
125. reproductive genetics
126. respiratory system
127. risk assessment
128. RNA
129. RNAi
130. skeletal system
131. splicing mechanisms
132. structure/function
133. susceptibility locus
134. tandem mass spectroscopy
135. teratogens
136. therapy
137. transcription
138. transgenic model
139. transplantation
140. transposable elements
141. triplet and other repeats
142. ultrasound diagnosis
143. uniparental disomy
144. viral vectors
145. visual system
146. X-inactivation
147. X-linked disease

 

Back to Call for Abstracts/Meeting Information